ATE87209T1 - Verwendung von adenosin-derivaten als antidementia-mittel. - Google Patents

Verwendung von adenosin-derivaten als antidementia-mittel.

Info

Publication number
ATE87209T1
ATE87209T1 AT87105843T AT87105843T ATE87209T1 AT E87209 T1 ATE87209 T1 AT E87209T1 AT 87105843 T AT87105843 T AT 87105843T AT 87105843 T AT87105843 T AT 87105843T AT E87209 T1 ATE87209 T1 AT E87209T1
Authority
AT
Austria
Prior art keywords
antidementia agent
agent
dementia
adenosin
derivatives
Prior art date
Application number
AT87105843T
Other languages
English (en)
Inventor
Masayoshi Goto
Nobutaka Demura
Tsutomu Osaki
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Application granted granted Critical
Publication of ATE87209T1 publication Critical patent/ATE87209T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT87105843T 1986-04-25 1987-04-21 Verwendung von adenosin-derivaten als antidementia-mittel. ATE87209T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61094738A JPH0696534B2 (ja) 1986-04-25 1986-04-25 抗痴呆剤
EP87105843A EP0253962B1 (de) 1986-04-25 1987-04-21 Verwendung von Adenosin-Derivaten als Anti-Dementia-Mittel

Publications (1)

Publication Number Publication Date
ATE87209T1 true ATE87209T1 (de) 1993-04-15

Family

ID=14118453

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87105843T ATE87209T1 (de) 1986-04-25 1987-04-21 Verwendung von adenosin-derivaten als antidementia-mittel.

Country Status (12)

Country Link
US (1) US5023244A (de)
EP (1) EP0253962B1 (de)
JP (1) JPH0696534B2 (de)
AT (1) ATE87209T1 (de)
AU (1) AU610822B2 (de)
CA (1) CA1287298C (de)
DE (1) DE3784977T2 (de)
DK (1) DK169656B1 (de)
IE (1) IE60886B1 (de)
IL (1) IL82298A0 (de)
PT (1) PT84765B (de)
ZA (1) ZA872879B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0723394B2 (ja) * 1986-11-27 1995-03-15 日本臓器製薬株式会社 新規アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物
EP0464206A4 (en) * 1989-03-24 1992-05-13 Daiichi Pharmaceutical Co., Ltd. Drug for improving brain function
US5206222A (en) * 1991-05-22 1993-04-27 Vanderbilt University Methods for the reduction of myocardial reperfusion injury
US5432164A (en) * 1991-10-24 1995-07-11 Novo Nordisk A/S C2,N6 -disubstituted adenosine derivatives
FR2685918B1 (fr) * 1992-01-08 1995-06-23 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR2687678B1 (fr) * 1992-01-31 1995-03-31 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
DK62692D0 (de) * 1992-05-14 1992-05-14 Novo Nordisk As
DK62592D0 (de) * 1992-05-14 1992-05-14 Novo Nordisk As
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
YU44900A (sh) 1998-01-31 2003-01-31 Glaxo Group Limited Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
YU81100A (sh) 1998-06-23 2003-10-31 Glaxo Group Limited Derivati 2-(purin-9-il)tetrahidrofuran-3,4 diola
AU2001273212A1 (en) 2000-07-07 2002-01-21 Neotherapeutics, Inc. Methods for treatment of drug-induced peripheral neuropathy and related conditions
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030069203A1 (en) * 2001-06-04 2003-04-10 Lee Steve S. Method for increasing human performance by reducing muscle fatigue and recovery time through oral administration of adenosine triphosphate
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
AR049384A1 (es) 2004-05-24 2006-07-26 Glaxo Group Ltd Derivados de purina
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224438A (en) * 1970-07-14 1980-09-23 Boehringer Mannheim Gmbh Adenosine-5'-carboxylic acid amides
US4029884A (en) * 1971-03-18 1977-06-14 Abbott Laboratories Adenosine-5'-carboxylic acid amides
US3864483A (en) * 1972-03-22 1975-02-04 Abbott Lab Adenosine-5{40 -carboxylic acid amides
US3992531A (en) * 1973-12-26 1976-11-16 Abbott Laboratories 2-Substituted adenosine-5'-carboxylates in the treatment of anginal pain
LU73052A1 (de) * 1975-07-24 1977-03-24
DE2610985A1 (de) * 1976-03-16 1977-09-29 Byk Gulden Lomberg Chem Fab Arzneimittel enthaltend beta-d-1 (6-amino-9h-purin-9-yl)-1-deoxyribofuranuronsaeurederivate
LU75374A1 (de) * 1976-07-13 1978-02-08
US4167565A (en) * 1976-11-08 1979-09-11 Abbott Laboratories Adenosine-5'-carboxamides and method of use

Also Published As

Publication number Publication date
DK209187D0 (da) 1987-04-24
IL82298A0 (en) 1987-10-30
IE871069L (en) 1987-10-25
AU7194687A (en) 1987-10-29
CA1287298C (en) 1991-08-06
JPH0696534B2 (ja) 1994-11-30
PT84765B (pt) 1989-12-29
AU610822B2 (en) 1991-05-30
DK209187A (da) 1987-10-26
DK169656B1 (da) 1995-01-09
ZA872879B (en) 1987-11-25
EP0253962A3 (en) 1988-11-30
PT84765A (en) 1987-05-01
US5023244A (en) 1991-06-11
JPS62252726A (ja) 1987-11-04
EP0253962A2 (de) 1988-01-27
EP0253962B1 (de) 1993-03-24
IE60886B1 (en) 1994-08-24
DE3784977D1 (de) 1993-04-29
DE3784977T2 (de) 1993-08-05

Similar Documents

Publication Publication Date Title
ATE87209T1 (de) Verwendung von adenosin-derivaten als antidementia-mittel.
DK172089D0 (da) 1,3-dioxolanderivater samt fremgangsmaade til fremstilling deraf
DK11992D0 (da) Epipodophyllotoxinglycosid-4'-phosphatderivater, deres fremstilling og anvendelse
DE68901043D1 (de) Waessriges pharmazeutisches praeparat.
IT8720059A0 (it) Process per la preparazione di (2,2)-paraciclofano e suoi derivati.
PT86660A (pt) Process for preparing adenosine 5:-carboxamide derivatives
DE3889302D1 (de) 9-(Acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde Mittel davon als aktiver Wirkstoff.
DK131887D0 (da) 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og deres anvendelse som laegemidler
IL84894A0 (en) Resolution of 1,4-dihydropyridine derivatives and optically active derivative salts of such derivatives
NO912545L (no) Nye 3,3'-ditiobis(propionsyrer) og estere derav samt fremgangsmaate for deres fremstilling
DE68927651D1 (de) Derivate von Fluorphosphonat-Nukleotiden
NZ233781A (en) (cyclic)phosphonyl-substituted guanine or adenine derivatives and pharmaceutical compositions
PT87550A (pt) Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same
ATE111104T1 (de) Nukleosid-derivate.
IT8448415A0 (it) Derivati della 1,4-diidropiridina, loro preparazione e loro impiego come medicamenti
PT87705A (pt) Process for the preparation of 6-deoxy guanine derivative
DK587689A (da) 2-azabicyclo(2,2,1)hept-5-en-2-eddikesyre og derivater deraf, deres fremstilling og anvendelse
FI890864A0 (fi) Anvaendning av 1,4-dihydropyridinderivat.
MX15990A (es) Derivados de acido 3-pirrolidiniltio-1- azabiciclo(3.2.0)hept-2-eno-2-carboxilico, su obtencion y usos.
NO901732L (no) Fremgangsmaate for fremstilling av 4-alkoksyalkyl-4-aminofenylpiperidiner og derivater derav.
FI904673A0 (fi) 2,6-dioksopiperidiinijohdannaisten valmistus
DE3854784D1 (de) Regelverfahren und vorrichtung ohne interferenz
FR2604176B1 (fr) Derives fonctionnels du 7-oxabicyclo(2.2.1)heptane a action therapeutique
FR2618151B1 (fr) Derives de piperidine, leur preparation et leur application en therapeutique
IT8449079A0 (it) Derivati della 1,4-diidropiridina, loro preparazione e loro impiegocome medicamenti

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time